大家在查： B2 Ms.Desmond ·艾克斯 Makarios WWT accidentaly 映入德斯蒙德图图级别的 DesmondCawley

代偿期

网络compensatory phase; compensatory stage; Compensation stage

代偿期

网络释义

代偿期

compensatory phase

... 代偿性心肥大 compensatory hypertrophy of heart 代偿期 compensatory phase 代偿性红细胞增多 compensatory polycythemi…

compensatory stage

1．微循环变化特点休克代偿期(compensatory stage)为休克早期，不同学者又将这一期称为非进展期(nonprogressive phase) …

Compensation stage

慢性肾功能不全... ... 二、发病过程( Progress) (一)代偿期( Compensation stage) （二）失代偿期( Discompensation stage) ...

compensatery stage

病理生理学笔记--休克-考试-生物谷 ... 缺血性缺氧期（ ischemic anoxia phase） 代偿期（ compensatery stage）休克（ shock…

compensated stage

肝硬化-我一直在快乐的飞翔... ... 营养障碍 nutritional disturbance 代偿期 compensated stage 失代偿期 decompensated stage ...

Compensated cirrhosis

王吉耀-肝硬化... ... ?Hepatic hydrothorax( 肝性胸水 ) Compensated cirrhosis( 代偿期 ) Decompensated cirrhosis( 失代偿 ) ...

Reserver stage

renal，肾脏病总论 - 豆丁网 ... ml/min • Reserver stage 代偿期 50-70 ml/min • Azotemia 氮质血症期 25-50 ...

Compensation period

代偿间期,Compensatory... ... ) decompensated period 失代偿期 ) Compensation period 代偿期 ) repayment period 偿还期间 ...

例句：

Objective To investigate the impact of health education on the living quality of the patients with hepatic cirrhosis and decompensation .

目的探讨健康教育对肝硬化失代偿期患者生存质量的影响。

There was significant difference of TBA between the patients with compensated and those with decompensated cirrhosis (P0. 01 ).

肝硬化失代偿期患者的 TBA 水准显著高于代偿期患者（P0 。01 ）。

Conclusions High HBV DNA level in patients with decompensated liver cirrhosis of hepatitis B may have effect on the decrease of PLT.

结论乙型肝炎肝硬化失代偿期患者高载量 HBVDNA 对血小板参数降低有一定的影响。

Conclusions ADV and Fuzhenghuayu capsule are beneficial for compensated liver cirrhosis patients with HBV DNA negative .

结论 ADV 联合扶正化瘀胶囊治疗 HBVDNA 阴性代偿期肝硬化具有显著的疗效。

About 73% had no cirrhosis , 24% had compensated cirrhosis, and 2% had decompensated cirrhosis at baseline .

约 73%的人没有肝硬化，24%有代偿性肝硬化，失代偿期在基线和 2%肝硬化。

Clinical study of Lamivudine treatment in patients with decompensated cirrhosis

拉米夫定在失代偿期肝硬化的临床应用研究

Clinical significance of peritoneal and retroperitoneal edema in patients with decompensated cirrhosis as demonstrated by CT scan

失代偿期肝硬化 CT 显示腹膜和腹膜后组织水肿的临床意义

Study on catheter lock solutions for maintenance of peripheral intravenous locks in patients with decompensated cirrhosis

肝硬化失代偿期病人静脉留置针封管液的探讨

Clinical characteristics and results of liver transplantation for end stage of liver cirrhosis with incidental liver neoplasm

肝硬化失代偿期并发意外肝癌患者的肝移植及其临床特点

Application of Drugs for Supplementing qi and Strengthening the Body Resistance to Grrhosis in Decompensatory Phase

益气扶正药物在肝硬变失代偿期的应用

Analysis of factors associated with prognosis in decompensated hepatic cirrhosis patients

失代偿期肝炎肝硬化患者的预后相关因素分析

Sodium metabolic disorder in decompensated cirrhosis patients and prognosis

失代偿期肝硬化患者钠代谢紊乱及其预后

A retrospective study of 42 death cases with decompensated hepatocirrhosis

42 例肝硬化失代偿期死亡病例回顾性分析

Sodium metabolic change in cirrhosis patients in decompensation

肝硬化失代偿期钠代谢的变化

Expression of ghrelin in gastric mucosa and serum ghrelin level in patients with decompensated cirrhosis

失代偿期肝硬化患者胃粘膜和血浆 ghrelin 改变及其临床意义

Analysis of prognosis of patients with decompensated liver cirrhosis using the criterion of the Model of End-Stage Liver Disease

失代偿期肝硬化患者的终末期肝病模型预后分析

肝硬化失代偿期低钠血症相关因素分析及护理

Clinical values of anti-virus treatment on decompensated cirrhosis patients

失代偿期肝硬化抗病毒治疗的临床价值

Ultrasonic feature analysis of compensated live cirrhosis

超声对代偿期肝硬化声像改变的分析

Drug therapy for complications of hepatocirrhosis during decompensatory period

肝硬化失代偿期合并症的药物治疗

代偿期

代偿期